RESUMO
Objective: To further improve the understanding of paroxysmal nocturnal hemoglobinuria (PNH), we retrospectively analyzed and summarized the clinical characteristics, treatment status, and survival status of patients with PNH in Zhejiang Province. Methods: This study included 289 patients with PNH who visited 20 hospitals in Zhejiang Province. Their clinical characteristics, comorbidity, laboratory test results, and medications were analyzed and summarized. Results: Among the 289 patients with PNH, 148 males and 141 females, with a median onset age of 45 (16-87) years and a peak onset age of 20-49 years (57.8% ). The median lactic dehydrogenase (LDH) level was 1 142 (604-1 925) U/L. Classified by type, 70.9% (166/234) were classical, 24.4% (57/234) were PNH/bone marrow failure (BMF), and 4.7% (11/234) were subclinical. The main clinical manifestations included fatigue or weakness (80.8%, 235/289), dizziness (73.4%, 212/289), darkened urine color (66.2%, 179/272), and jaundice (46.2%, 126/270). Common comorbidities were hemoglobinuria (58.7% ), renal dysfunction (17.6% ), and thrombosis (15.0% ). Moreover, 82.3% of the patients received glucocorticoid therapy, 70.9% required blood transfusion, 30.7% used immunosuppressive agents, 13.8% received anticoagulant therapy, and 6.3% received allogeneic hematopoietic stem cell transplantation. The 10-year overall survival (OS) rate was 84.4% (95% CI 78.0% -91.3% ) . Conclusion: Patients with PNH are more common in young and middle-aged people, with a similar incidence rate between men and women. Common clinical manifestations include fatigue, hemoglobinuria, jaundice, renal dysfunction, and recurrent thrombosis. The 10-year OS of this group is similar to reports from other centers in China.
Assuntos
Hemoglobinúria Paroxística , Humanos , Hemoglobinúria Paroxística/epidemiologia , Hemoglobinúria Paroxística/diagnóstico , Hemoglobinúria Paroxística/terapia , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Adolescente , Estudos Retrospectivos , Adulto Jovem , Idoso , China/epidemiologia , Idoso de 80 Anos ou maisRESUMO
18 patients with malignant effusions were treated with continuous intraperitoneal, intrapleural, or intrapericardial infusion of methotrexate (MTX) 30 mg/m2 per d combined with simultaneous intravenous administration of leucovorin at a dose rate calculated to yield an equimolar concentration in the serum. In the serum the geometric mean steady-state MTX concentration was 0.95 microM, whereas it was 24 microM in the peritoneal, 213 microM in the pleural, and 434 microM in the pericardial cavities. Mean clearance was 6.6 ml/min from the peritoneal cavity, 2.6 ml/min from the pleural cavity, and 0.14 ml/min from the pericardial cavity. Leucovorin provided sufficient protection to allow the duration of infusion to be escalated from 24 to 120 h before myelosuppression was encountered. Marrow thymidylate synthetase activity was inhibited by an average of 46% compared to 86% inhibition in malignant cells in the effusions. Flow cytometric analysis showed no perturbation of the cell cycle phase distribution of marrow cells. All eight of the evaluable patients have responded: three received no other form of therapy, five also received systemic hormonal or chemotherapy. This study demonstrated that tumors confined to third space body fluids can be given very high concentration x time exposures to MTX with minimal systemic toxicity.
Assuntos
Leucovorina/administração & dosagem , Metotrexato/administração & dosagem , Neoplasias/tratamento farmacológico , Quimioterapia Combinada , Exsudatos e Transudatos/metabolismo , Feminino , Humanos , Infusões Parenterais , Cinética , Metotrexato/metabolismoRESUMO
A representative sample of 35-year old residents of Zurich was examined with the PTN-system to determine their periodontal treatment needs. 8.8% required no periodontal treatment. An additional 7.0% required only oral hygiene instruction and motivation to restore their gingival health. 37.1% of the sample needed removal of marginal irritants. 47.1% of the sample population had periodontal pockets in two or more quadrants, in need of surgical treatment (curettage, flap surgery). Responses to a questionnaire completed by all participants in the study revealed a strong desire on their part to retain their teeth. However, knowledge of periodontal prophylactic measures and individual oral hygiene was inadequate.